Suchergebnisse - "Hallett, Sadie R"

PubPharm (7)

1

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

enthalten in: bioRxiv.org | 2024

von Dupont, L. | Snell, L. | Graham, C. | +29

2

The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis

enthalten in: iScience | 2024

von Coleman, J. | Tattersall, L. | Yianni, V. | +10

3

ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants

enthalten in: bioRxiv.org | 2023

von Seow, J. | Graham, C. | Hallett, S. | +13

4

LARP4A and LARP4B in cancer : The new kids on the block

enthalten in: The international journal of biochemistry & cell biology | 2023

von Coleman, J. | Hallett, S. | Grigoriadis, A. | +1

5

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

enthalten in: Cell reports | 2022

von Seow, J. | Graham, C. | Hallett, S. | +15

6

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

enthalten in: Nature microbiology | 2021

von Dupont, L. | Snell, L. | Graham, C. | +29

UpdateOf: medRxiv. 2021 Jun 08;:. - PMID 34127977

7

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

enthalten in: medRxiv : the preprint server for health sciences | 2021

von Dupont, L. | Snell, L. | Graham, C. | +29

UpdateIn: Nat Microbiol. 2021 Nov;6(11):1433-1442. - PMID 34654917

1
[1]